
NYSE:SNV
This summary was created by AI, based on 1 opinions in the last 12 months.
Synovus Financial (SNV-N) is recognized as a high-quality and trusted regional bank, currently benefitting from its merger with Pinnacle, which promises promising growth potential in the near term. Analysts have noted the favorable conditions in the banking sector, particularly with loan growth being robust and a steepening yield curve. The central premise is that falling short-term interest rates are advantageous for banks like Synovus, enhancing their profitability. Additionally, there has been a healthy uptick in capital markets business, contributing to overall positive sentiment around the stock. With a competitive yield of 3.40% and a targeted price of $55.87 from analysts, the future appears bright for Synovus Financial.
Synovus Financial is a American stock, trading under the symbol SNV (previously SNV-N on Stockchase) on the New York Stock Exchange (SNV). It is usually referred to as NYSE:SNV or SNV
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on SNV (previously SNV-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY on WEAKNESS. Read the latest stock experts' ratings for Synovus Financial.
Synovus Financial was recommended as a Top Pick by Benj Gallander on 2012-12-14. Read the latest stock experts ratings for Synovus Financial.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Synovus Financial.
Synovus Financial is covered by Stockchase experts and is worth watching.
On 2025-12-31, Synovus Financial (SNV) stock closed at a price of $51.50.
High-quality, trusted regional bank. Merging with Pinnacle, showing good promise for even short-term growth. Trades at a good multiple. Loan growth is good. Yield curve is steepening, with short-term interest rates falling, and that's very good for banks. A fair bit of capital markets business is also happening. Yield is 3.40%.
(Analysts’ price target is $55.87)